Clinical Trial Update: A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome [Phase 1]

View source ↗

Summary

Phase I/II clinical trial evaluating Megestrol Acetate alone and in combination with Dronabinol for HIV wasting syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• HIV Infection
• HIV Wasting Syndrome

Drugs mentioned

• Dronabinol (dronabinol)
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cachexia, HIV Infections | Phase 1 | Status: COMPLETED